Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

BMS-Pfizer Alliance to Unveil Real-World Data Analyses - Cost, Safety and Comparative Effectiveness Findings Associated with Oral Anticoagulants in Non-Valvular Atrial Fibrillation

Business Wire November 10, 2017

Spark Therapeutics and Pfizer Amend License Agreement for Investigational SPK-9001 in Hemophilia B

GlobeNewswire November 7, 2017

Global Experts Call for Action on Vaccination Apathy, and More Protection for Older Adults Against Infectious Diseases

PR Newswire Europe Non Regulatory November 7, 2017

Servier et Pfizer annoncent que les résultats préliminaires des premières études d'UCART19 chez l’homme seront présentés lors du 59è congrès annuel de l'American Society of Hematology (ASH)

Business Wire November 1, 2017

Servier and Pfizer Announce Preliminary Results of the First-in-Human Trials of UCART19 Will Be Presented at the 59th American Society of Hematology (ASH) Annual Meeting

Business Wire November 1, 2017

Encycle Therapeutics announces discovery collaboration with Pfizer Inc.

GlobeNewswire November 1, 2017

11 Technical Levels Discussed On Tuesday's PreMarket Prep

Benzinga.com  October 31, 2017

Pfizer Inc. to Host Earnings Call

Accesswire October 31, 2017

PFIZER REPORTS THIRD-QUARTER 2017 RESULTS

Business Wire October 31, 2017

Thinking about buying stock in Adamas Pharmaceuticals, Diamond Offshore Drilling, Merck & Company Incorporated, Pfizer Inc, or Under Armour?

PR Newswire October 30, 2017

One Year Maintenance and Switching Data in Patients with Crohn’s Disease Support the Use of INFLECTRA®* (infliximab CT-P13) in IBD1

Business Wire October 29, 2017

Wall Street's M&A Chatter From October 25: Sprint-T-Mobile, Trade Desk, Pfizer, Dynegy

Benzinga.com  October 26, 2017

Stock Performance Review on Drug Makers Industry -- Pfizer, Sanofi, Heron Therapeutics, and Aerie Pharma

PR Newswire October 20, 2017

Pfizer Presents Full Results from Phase 2 Study of Next-Generation Investigational ALK-Inhibitor Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non-Small Cell Lung Cancer

Business Wire October 16, 2017

U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV

Business Wire October 12, 2017

A Deep Dive Into MannKind's Big Bet On Afrezza

Benzinga.com  October 11, 2017

Should you invest in Facebook, Helios and Matheson Analytics Inc, Nokia Corporation, NVIDIA, or Pfizer?

PR Newswire October 10, 2017

Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business

Business Wire October 10, 2017

Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result

Benzinga.com  October 9, 2017

Pfizer Launches Novel Programs to Put Important Support Services at the Fingertips of Cancer Patients

Business Wire October 5, 2017